Sign in
  • Home
  • News Bytes
  • Lead Story
  • Editor’s Zone
  • Industry Reports
  • Events
  • Expert Column
  • Policy
  • Startup Tracker
  • Face to Face
  • Chat with BioVoice
  • BioVoice eMag
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Sunday, July 26, 2026
  • Subscribe
  • SUBSCRIBE
  • Write to Us
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
BioVoice BioVoiceNews
wellness India Expo
BioVoice BioVoice
  • Home
  • News Bytes
    • Diagnostics

      Forus Health launches portable connected eye-care platform

      Events

      MTaI to convene policymakers, diplomats and industry leaders to discuss FTAs’…

      BioPharma

      OneSource Specialty Pharma, Formycon enter strategic manufacturing partnership for biosimilars

      BioComputing

      Novogene Europe launches untargeted metabolomics service through Cambridge Omics Centre

      BioPharma

      Emcure to acquire remaining 12.05% stake in Gennova

  • Lead Story
    • BioPharma

      Emcure Pharma reduces Poviztra® starting dose price by 55% at Rs…

      Biotech

      India’s bioeconomy set to hit $300B as patent cliff fuels innovation…

      BioPharma

      Biologics, mRNA and Bio Foundries to set the course for pharma’s…

      Diagnostics

      Yoda Diagnostics hosts ‘Yoda Early Mind Summit’ in New Delhi

      Biovoice Shreehas Tambe
      People

      Shreehas Tambe appointed CEO & MD of Biocon Limited, effective April…

  • Editor’s Zone
    • Health Policy

      A Silent Victory: How Uttar Pradesh reversed its Encephalitis crisis

      Policy

      Beyond Trade: How the EU–India FTA reshapes life-sciences industry

      Editor’s Zone

      Safeguarding Our Healers – India’s Doctors Need Protection

      Editor’s Zone

      Lost in Translation? India’s Biologics R&D Shortfall

      Editor’s Zone

      Bridging Science and Business: The Missing Link in Bioscience Innovation

  • Industry Reports
    • Industry Reports

      India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

      Industry Reports

      Inviting your participation in the upcoming India MedTech Handbook 2024

      Industry Reports

      BioVoice News & ICPA team presents India MedTech Handbook 2023 to…

      MedTech

      India MedTech Handbook 2023 launched at the MedTech Conference in USA

      MedTech

      Releasing Soon: India MedTech Handbook 2023 powered by ICPA & BioVoice…

  • Events
    • Events

      MTaI to convene policymakers, diplomats and industry leaders to discuss FTAs’…

      Academia

      HAI Conclave 2026 spotlights responsible AI adoption in healthcare

      video
      Events

      Digitalization has democratized healthcare: Experts at BioVoice News e-Conference

      Events

      BioVoice News to host e-Conference on India’s roadmap to Digital Healthcare…

      video
      Events

      Digitally powered smart labs are the future of biopharma R&D: Experts

  • Expert Column
    • Expert Column

      Reimagining preventive medicine through genomics, AI, and early risk detection

      Expert Column

      Early cancer detection begins with getting the first step right

      Expert Column

      Leveraging AI to Strengthen India’s Healthcare System

      Expert Column

      The Rise of HealthTech Startups: Innovations Shaping the Future of Medicine

      Expert Column

      How India is Countering the Growing Challenge of Drug-Resistant TB

  • Policy
    • Hospitals

      WHO redesignates LVPEI as collaborating centre for blindness prevention

      Health Policy

      TB survivors seek govt clarification on continuity of TB medicines &…

      Events

      BioAsia 2026 positions Telangana as a global TechBio powerhouse

      AgriPolicy

      Budget 2026 charts a technology-led path for Indian agriculture

      Health

      Budget 2026: Healthcare skill development & medical tourism gets due attention

  • Startup Tracker
    • Diagnostics

      Sciverse opens integrated diagnostics research centre in Pune

      Startup Tracker

      IIIT Hyderabad incubated biotech startup BioReform bags global award for ditching…

      Startup Tracker

      Gut Clinic raises $1 million in seed round to build India’s…

      Startup Tracker

      IAN Alpha Fund co-leads ₹70 Cr Series A funding round in…

      Biovoice News invests
      Startup Tracker

      Pandorum Technologies raises US$18 Million in Series B to advance global…

  • Face to Face
    • Face to Face

      “Research must be designed for translation, not just for publications”: Dr…

      video
      Face to Face

      Face to Face with BioVoice News: Dr Sajeev Nair, Founder &…

      video
      Face to Face

      FACE TO FACE: Dr Taslimarif Saiyed, Director and CEO, Centre for Cellular…

      video
      Face to Face

      FACE TO FACE: Harish Bisam, Founder & MD, Bisam Pharmaceuticals

      video
      Face to Face

      FACE TO FACE: Dr Pawan Dhar, Executive Director, CVJ Centre for…

  • Chat with BioVoice
    • Chat with BioVoice

      “Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

      Chat with BioVoice

      “AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

      Chat with BioVoice

      “Our focus is on identifying biological mechanisms that may offer alternative…

      Chat with BioVoice

      “We plan to invest Rs 50 crore in phase for R&D…

      Chat with BioVoice

      “Merck has made significant efforts to strengthen lab solutions and R&D…

  • BioVoice eMag
    • BioVoice eMag

      BioVoice eMagazine November 2025 | Issue 10 | Volume 6

      BioVoice eMag

      BioVoice eMagazine October 2025 | Issue 9 | Volume 6

      BioVoice eMag

      BioVoice eMagazine September 2025 | Issue 8 | Volume 6

      BioVoice eMag

      BioVoice eMagazine July-August 2025 | Issue 7 | Volume 6

      BioVoice eMag

      BioVoice eMagazine June 2025 | Issue 6 | Volume 6

Home Biotech Biosupplier Avantor announces new brand identity
  • Biotech
  • Biosupplier
  • News Bytes
  • Top News

Avantor announces new brand identity

New identity signals continued integration with VWR and ongoing commitment to customers for the company which has significant operations in Asia Pacific and India

By BioVoice Correspondent -
July 18, 2018
0
125
Share on Facebook
Tweet on Twitter

Radnor/New Delhi: Following the acquisition of VWR in 2017, Avantor has now introduced a new logo and visual identity, signaling the company’s position as a leading global provider of products, services and solutions for professionals in the life sciences and advanced technology industries.

The company has got significant operations in Asia Pacific and India. Avantor’s Panoli plant in Goa is ISO 9001:2008 certified and approved by the Indian Food and Drug Administration. The facility produces high-purity solvents, salts and solutions under cGMP conditions that comply with Indian Pharmacopoeia (IPC), U.S. Pharmacopeia (USP), National Formulary (NF), European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP) and British Pharmacopoeia (BP).

“This marks an exciting milestone for Avantor as our integration with VWR continues,” said Michael Stubblefield, CEO of Avantor. “We’re transforming our global visual presence to give a fresh, distinctive expression of the new Avantor and our mission to set science in motion to create a better world.”

The new visual identity captures two strong legacies in a unified symbol. The fluid curve symbolizes the agility of a company that is always ready to adapt to customer needs. It is the infinite path of scientific discovery, signifying the momentum that propels Avantor into the future.

The new logo unveiled by Avantor. 

Following the rebranding, Avantor will continue as the corporate name and entity, while the VWR name remains as the channel brand, representing the primary ordering platform for customers. The new visual identity will be implemented across all aspects of the company, presenting a common, aligned identity that reflects the integration of the two businesses.

The new identity will be rolled out over time on all company platforms, including facility signage, web properties, promotional materials, product labels and documentation.

The change to the logo will not impact the company’s e-commerce functionality, product quality or specifications, product availability or service delivery performance.

Stubblefield added, “With this new logo and visual identity, we are launching a global brand that stands for the things that matter to our customers: quality and choice, trusted expertise, collaborative service, and innovative, customized solutions.”

VIABioVoice New Delhi Bureau
  • TAGS
  • Avantor
  • Avantor India
  • India
  • Logo
  • New
  • VWR
Previous articleNew agreements with HIV drug suppliers to save $324 million
Next articleICMR’s essay competition open for medical students, entries by 15th August
BioVoice Correspondent

RELATED ARTICLESMORE FROM AUTHOR

Diagnostics

Forus Health launches portable connected eye-care platform

Biotech

CDSCO approves Takeda’s Qdenga as India’s first dengue vaccine

Events

MTaI to convene policymakers, diplomats and industry leaders to discuss FTAs’ role in India’s MedTech future

Face to Face

Face to Face

“Research must be designed for translation, not just for publications”: Dr...

Rahul Koul - December 18, 2025
390
Dr Sagar Sengupta, Director, National Institute of Biomedical Genomics (NIBMG) and Director (Additional Charge), National Brain Research Centre (NBRC) shared his insights on the latest initiatives, importance of industry-academia collaboration, increased government funding, and evolution of research ecosystem

e-Conference

https://www.youtube.com/watch?v=Nku-bLFGpBI&t=491s

Subscribe Our Newsletter


Chat with BioVoice

Chat with BioVoice

“Biologics and biosimilars represent Veeda’s second-highest strategic priority after clinical trials”

Rahul Koul - February 26, 2026
224
Binoy Gardi, Managing Director and Group CEO, Veeda Lifesciences shared insights on his latest role and top priorities; the company's latest initiatives, outcomes of key acquisitions and future plans

“AI’s biggest contribution in cardiac monitoring is its speed and efficiency”

January 28, 2026

“Our focus is on identifying biological mechanisms that may offer alternative...

January 19, 2026

R&D

BioPolicy

DBT & BIRAC host webinar on biomanufacturing & biofoundry initiative on...

R&D

New magnetic nanoparticles may help treat cancer

Events

Events

MTaI to host diplomatic roundtable on FTAs and healthcare integration

Industry Reports

India Biotech Outlook 2025: The India Advantage at BIO Boston 2025

Events

BioAsia 2025: C4IR Telangana & WEF to spearhead high-level dialogues on...

Events

Countdown begins to BioAsia 2025: A unique platform to showcase startup...

BioVoice
ABOUT US
Welcome to BioVoice News, India’s leading bioscience B2B media network. It serves as credible go-to source for the latest news, insights, interviews and analysis from the dynamic worlds of BioTech, HealthTech and AgriTech. Read More
Contact us: connect@biovoicenews.com
FOLLOW US
  • Terms of Use
  • Privacy
  • Advertise
  • Contact
© Copyright © 2022-2025 BioVoiceNews.com All rights reserved.